11/20
01:11 pm
gnft
GENFIT announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market [Yahoo! Finance]
Neutral
Report
GENFIT announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market [Yahoo! Finance]
11/20
12:10 pm
gnft
GENFIT Reports Third Quarter 2025 Financial Information and Provides a Corporate Update
Neutral
Report
GENFIT Reports Third Quarter 2025 Financial Information and Provides a Corporate Update
11/20
12:00 pm
gnft
GENFIT announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market
Neutral
Report
GENFIT announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market
11/10
02:01 am
gnft
GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF [Yahoo! Finance]
Medium
Report
GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF [Yahoo! Finance]
11/10
01:45 am
gnft
GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF
Medium
Report
GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF
11/10
01:41 am
gnft
GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting® 2025 [Yahoo! Finance]
Medium
Report
GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting® 2025 [Yahoo! Finance]
11/10
01:30 am
gnft
GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting® 2025
Medium
Report
GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting® 2025
10/30
04:00 pm
gnft
GENFIT announces intention to voluntarily delist American Depositary Shares from The Nasdaq Global Select Market
Medium
Report
GENFIT announces intention to voluntarily delist American Depositary Shares from The Nasdaq Global Select Market
10/28
05:10 pm
gnft
GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver Meeting® 2025
Low
Report
GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver Meeting® 2025
10/14
12:14 pm
gnft
GENFIT (NASDAQ:GNFT) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
GENFIT (NASDAQ:GNFT) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
9/24
08:07 am
gnft
GENFIT (NASDAQ:GNFT) had its price target lowered by analysts at HC Wainwright from $9.00 to $7.00. They now have a "buy" rating on the stock.
Low
Report
GENFIT (NASDAQ:GNFT) had its price target lowered by analysts at HC Wainwright from $9.00 to $7.00. They now have a "buy" rating on the stock.
9/22
04:56 pm
gnft
GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
High
Report
GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
9/22
04:10 pm
gnft
GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update
High
Report
GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update
9/19
04:34 pm
gnft
GENFIT Announces Discontinuation of its VS-01 Program in ACLF: VS-01 Development Refocused on UCD [Yahoo! Finance]
Medium
Report
GENFIT Announces Discontinuation of its VS-01 Program in ACLF: VS-01 Development Refocused on UCD [Yahoo! Finance]
9/19
04:10 pm
gnft
GENFIT Announces Discontinuation of its VS-01 Program in ACLF: VS-01 Development Refocused on UCD
Medium
Report
GENFIT Announces Discontinuation of its VS-01 Program in ACLF: VS-01 Development Refocused on UCD